Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland

Joyce A. Schroeder, Melissa C. Thompson, Melissa Mockensturm Gardner, Sandra J Gendler

Research output: Contribution to journalArticle

267 Citations (Scopus)

Abstract

MUC1 is a large (>400 kDa), heavily glycosylated transmembrane protein that is aberrantly expressed on greater than 90% of human breast carcinomas and subsequent metastases. The precise function of MUC1 overexpression in tumorigenesis is unknown, although various domains of MUC1 have been implicated in cell adhesion, cell signaling, and immunoregulation. Stimulation of the MDA-MB-468 breast cancer line as well as mouse mammary glands with epidermal growth factor results in the co-immunoprecipitation of MUC1 with a tyrosine-phosphorylated protein of ∼180 kDa. We have generated transgenic lines overexpressing full-length (MMF), cytoplasmic tail deleted (ΔdCT), or tandem repeat deleted (ΔTR)-human MUC1 under the control of the mouse mammary tumor virus promoter to further examine the role of MUC1 in signaling and tumorigenesis. Immunoprecipitation experiments revealed that full-length transgenic MUC1 physically associates with all four erbB receptors, and co-localizes with erbB1 in the lactating gland. Furthermore, we detected a sharp increase in ERK1/2 activation in MUC1 transgenic mammary glands compared with Muc1 null and wild-type animals. These results point to a novel function of increased MUC1 expression, potentiation of erbB signaling through the activation of mitogenic MAP kinase pathways.

Original languageEnglish (US)
Pages (from-to)13057-13064
Number of pages8
JournalJournal of Biological Chemistry
Volume276
Issue number16
DOIs
StatePublished - Apr 20 2001

Fingerprint

Human Mammary Glands
Mitogen-Activated Protein Kinases
Immunoprecipitation
Epidermal Growth Factor Receptor
Carcinogenesis
Chemical activation
Breast Neoplasms
Cell signaling
Mouse mammary tumor virus
Tandem Repeat Sequences
Wild Animals
Cell adhesion
Viruses
Epidermal Growth Factor
Cell Adhesion
Carcinogens
Tyrosine
Tail
Tumors
Animals

ASJC Scopus subject areas

  • Biochemistry

Cite this

Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland. / Schroeder, Joyce A.; Thompson, Melissa C.; Gardner, Melissa Mockensturm; Gendler, Sandra J.

In: Journal of Biological Chemistry, Vol. 276, No. 16, 20.04.2001, p. 13057-13064.

Research output: Contribution to journalArticle

@article{f8cb4b0550f94a2e96e50cf15e3996ec,
title = "Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland",
abstract = "MUC1 is a large (>400 kDa), heavily glycosylated transmembrane protein that is aberrantly expressed on greater than 90{\%} of human breast carcinomas and subsequent metastases. The precise function of MUC1 overexpression in tumorigenesis is unknown, although various domains of MUC1 have been implicated in cell adhesion, cell signaling, and immunoregulation. Stimulation of the MDA-MB-468 breast cancer line as well as mouse mammary glands with epidermal growth factor results in the co-immunoprecipitation of MUC1 with a tyrosine-phosphorylated protein of ∼180 kDa. We have generated transgenic lines overexpressing full-length (MMF), cytoplasmic tail deleted (ΔdCT), or tandem repeat deleted (ΔTR)-human MUC1 under the control of the mouse mammary tumor virus promoter to further examine the role of MUC1 in signaling and tumorigenesis. Immunoprecipitation experiments revealed that full-length transgenic MUC1 physically associates with all four erbB receptors, and co-localizes with erbB1 in the lactating gland. Furthermore, we detected a sharp increase in ERK1/2 activation in MUC1 transgenic mammary glands compared with Muc1 null and wild-type animals. These results point to a novel function of increased MUC1 expression, potentiation of erbB signaling through the activation of mitogenic MAP kinase pathways.",
author = "Schroeder, {Joyce A.} and Thompson, {Melissa C.} and Gardner, {Melissa Mockensturm} and Gendler, {Sandra J}",
year = "2001",
month = "4",
day = "20",
doi = "10.1074/jbc.M011248200",
language = "English (US)",
volume = "276",
pages = "13057--13064",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "16",

}

TY - JOUR

T1 - Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland

AU - Schroeder, Joyce A.

AU - Thompson, Melissa C.

AU - Gardner, Melissa Mockensturm

AU - Gendler, Sandra J

PY - 2001/4/20

Y1 - 2001/4/20

N2 - MUC1 is a large (>400 kDa), heavily glycosylated transmembrane protein that is aberrantly expressed on greater than 90% of human breast carcinomas and subsequent metastases. The precise function of MUC1 overexpression in tumorigenesis is unknown, although various domains of MUC1 have been implicated in cell adhesion, cell signaling, and immunoregulation. Stimulation of the MDA-MB-468 breast cancer line as well as mouse mammary glands with epidermal growth factor results in the co-immunoprecipitation of MUC1 with a tyrosine-phosphorylated protein of ∼180 kDa. We have generated transgenic lines overexpressing full-length (MMF), cytoplasmic tail deleted (ΔdCT), or tandem repeat deleted (ΔTR)-human MUC1 under the control of the mouse mammary tumor virus promoter to further examine the role of MUC1 in signaling and tumorigenesis. Immunoprecipitation experiments revealed that full-length transgenic MUC1 physically associates with all four erbB receptors, and co-localizes with erbB1 in the lactating gland. Furthermore, we detected a sharp increase in ERK1/2 activation in MUC1 transgenic mammary glands compared with Muc1 null and wild-type animals. These results point to a novel function of increased MUC1 expression, potentiation of erbB signaling through the activation of mitogenic MAP kinase pathways.

AB - MUC1 is a large (>400 kDa), heavily glycosylated transmembrane protein that is aberrantly expressed on greater than 90% of human breast carcinomas and subsequent metastases. The precise function of MUC1 overexpression in tumorigenesis is unknown, although various domains of MUC1 have been implicated in cell adhesion, cell signaling, and immunoregulation. Stimulation of the MDA-MB-468 breast cancer line as well as mouse mammary glands with epidermal growth factor results in the co-immunoprecipitation of MUC1 with a tyrosine-phosphorylated protein of ∼180 kDa. We have generated transgenic lines overexpressing full-length (MMF), cytoplasmic tail deleted (ΔdCT), or tandem repeat deleted (ΔTR)-human MUC1 under the control of the mouse mammary tumor virus promoter to further examine the role of MUC1 in signaling and tumorigenesis. Immunoprecipitation experiments revealed that full-length transgenic MUC1 physically associates with all four erbB receptors, and co-localizes with erbB1 in the lactating gland. Furthermore, we detected a sharp increase in ERK1/2 activation in MUC1 transgenic mammary glands compared with Muc1 null and wild-type animals. These results point to a novel function of increased MUC1 expression, potentiation of erbB signaling through the activation of mitogenic MAP kinase pathways.

UR - http://www.scopus.com/inward/record.url?scp=0035918199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035918199&partnerID=8YFLogxK

U2 - 10.1074/jbc.M011248200

DO - 10.1074/jbc.M011248200

M3 - Article

C2 - 11278868

AN - SCOPUS:0035918199

VL - 276

SP - 13057

EP - 13064

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 16

ER -